线粒体作为辅助生殖治疗靶点
线粒体在卵母细胞发育中起关键作用,功能异常可致生殖失败。本文综述靶向线粒体的药物(辅酶Q10、米托醌、雷帕霉素、烟酰胺单核苷酸)及线粒体替代疗法(母源纺锤体移植、原核移植等)在辅助生殖中的应用与证据,指出母源纺锤体移植临床试验结果有前景但需更大研究确认安全性与有效性,线粒体替代疗法面临伦理与立法障碍。
要点
- 辅酶Q10、米托醌、雷帕霉素、烟酰胺单核苷酸等药物靶向线粒体功能,在改善辅助生殖结局方面显示前景。
- 母源纺锤体移植和原核移植有预防线粒体疾病传递及改善卵母细胞质量的潜力,临床试验结果有前景但需更大研究确认。
- 自体生殖系线粒体能量转移初期显示前景,但临床试验未能证明显著获益。
核心结论
- 线粒体是辅助生殖潜在的诊断和治疗靶点,靶向线粒体的药物和线粒体替代疗法在辅助生殖中显示一定前景,但线粒体替代疗法的广泛实施面临伦理和立法挑战。
研究设计与样本
- 综述,检索范围未在原文摘要中报告。
主要发现
- 靶向线粒体功能的药物包括抗氧化剂辅酶Q10和米托醌、哺乳动物雷帕霉素靶蛋白信号通路抑制剂雷帕霉素以及烟酰胺单核苷酸,在改善辅助生殖结局方面显示前景。
- 自体生殖系线粒体能量转移初期显示前景,但临床试验未能证明显著获益。
- 母源纺锤体移植和原核移植有预防线粒体疾病传递和改善卵母细胞质量的潜力;母源纺锤体移植临床试验显示有前景的结果,但需要更大规模研究确认安全性和有效性。
局限性
- 原文指出母源纺锤体移植临床试验虽显示有前景的结果,但需要更大规模研究来确认安全性和有效性。
- 原文指出伦理和立法挑战使线粒体替代疗法的广泛实施复杂化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mitochondria are essential organelles with specialized functions, which play crucial roles in energy production, calcium homeostasis, and programmed cell death. In oocytes, mitochondrial populations are inherited maternally and are vital for developmental competence. Dysfunction in mitochondrial quality control mechanisms can lead to reproductive failure. Due to their central role in oocyte and embryo development, mitochondria have been investigated as potential diagnostic and therapeutic targets in assisted reproduction. Pharmacological agents that target mitochondrial function and show promise in improving assisted reproduction outcomes include antioxidant coenzyme Q10 and mitoquinone, mammalian target of rapamycin signaling pathway inhibitor rapamycin, and nicotinamide mononucleotide. Mitochondrial replacement therapies (MRTs) offer solutions for infertility and mitochondrial disorders. Autologous germline mitochondrial energy transfer initially showed promise but failed to demonstrate significant benefits in clinical trials. Maternal spindle transfer (MST) and pronuclear transfer hold potential for preventing mitochondrial disease transmission and improving oocyte quality. Clinical trials of MST have shown promising outcomes, but larger studies are needed to confirm safety and efficacy. However, ethical and legislative challenges complicate the widespread implementation of MRTs.
引用
- Yildirim RM, Seli E. Mitochondria as therapeutic targets in assisted reproduction. Hum Reprod. 2024. PMID: 39066614. doi:10.1093/humrep/deae170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。